Civil & Administrative

#2021-1287Decree No. 2021-1287 of October 1, 2021 on the Control of Manufacture and Trade of Drug Precursors in Overseas Territories

🇫🇷France··Other·Medium Impact·View source ↗

AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.

🇬🇧 English

This law updates the regulations for the production and trade of drug precursors in French overseas territories. It ensures that certain previous regulations now apply to regions like New Caledonia, French Polynesia, and others. Operators must report specific data to the industry ministry to strengthen oversight.

AI-generated summary. May contain errors. Refer to official sources for legal decisions.

Key Changes

  • The decree expands the applicability of existing regulations to French overseas territories.
  • Operators in these regions must report specific information about drug precursors to the French industry ministry.
  • Procedures for approving, suspending, and revoking import/export licenses are updated.

Obligations

What this law requires

high

Approved or registered operators in Saint-Barthélemy, Saint-Pierre-et-Miquelon, Wallis and Futuna Islands, French Polynesia, and New Caledonia must submit annual data to the Ministry responsible for industry by February 15th following the fiscal year, including: beginning and ending inventory of classified substances, quantities of destroyed substances with destruction declarations, names and contact information of intermediaries involved, and names and contact information of recipient entities for exports outside the territory.

Approved or registered operators of drug precursors in French overseas territories (Saint-Barthélemy, Saint-Pierre-et-Miquelon, Wallis and Futuna, French Polynesia, New Caledonia)
reporting
high

A copy of approvals and registrations (mentioned in articles 3, 4, and 9) delivered to operators in New Caledonia and French Polynesia must be transmitted to the competent authorities of these territories.

French industrial ministry or competent federal authority issuing approvals and registrations
disclosure
high

A copy of decisions suspending or withdrawing approvals (article 6) and suspensions or withdrawals of registrations (article 11) must be transmitted to the competent authorities of New Caledonia and French Polynesia.

French industrial ministry or competent federal authority issuing suspension or withdrawal decisions
disclosure
medium

A copy of export authorizations to New Caledonia (issued under articles 7, 12, and 17) must be transmitted to the competent health authority of New Caledonia.

French industrial ministry or competent federal authority issuing export authorizations
disclosure
medium

A copy of import authorizations to French Polynesia and export authorizations from French Polynesia (issued under articles 7, 8, 12, 16, and 17) must be transmitted to the competent health and customs authorities of French Polynesia.

French industrial ministry or competent federal authority issuing import and export authorizations
disclosure

Affected Parties

Drug precursor manufacturers and traders in French overseas territoriesRegulatory authorities in New Caledonia, French Polynesia, etc.

Tags

drug_precursors,regulation,overseas_territories